Baraliakos, Xenofon
Sewerin, Philipp
de Miguel, Eugenio
Pournara, Effie
Kleinmond, Christine
Wiedon, Annette
Behrens, Frank
Funding for this research was provided by:
Novartis
Article History
Received: 3 June 2020
Accepted: 5 November 2020
First Online: 21 November 2020
Ethics approval and consent to participate
: Not applicable.
: All authors provide their consent for publication of this manuscript.
: XB received grant/research support from: AbbVie, Novartis, Consultant for: AbbVie, BMS, Celgene, Chugai, Merck, Novartis, Pfizer, UCB, Speakers bureau: AbbVie, BMS, Celgene, Chugai, Merck, Novartis, Pfizer, UCB. PS received grant/research support from: AbbVie, Celgene, Chugai, Janssen-Cilag, Lilly, Novartis, Pfizer, UCB; Consultant for: AbbVie, Biogen, BMS, Celgene, Chugai, Hexal, Janssen-Cilag, Lilly, Novartis, Pfizer, Roche, Sanofi-Genzyme, Swedish Orphan Biovitrum, UCB; Speakers bureau: AbbVie, Biogen, BMS, Celgene, Chugai, Hexal, Janssen-Cilag, Lilly, Novartis, Pfizer, Roche, Sanofi-Genzyme, Swedish Orphan Biovitrum, UCB. EDM received grant/research support from: AbbVie, Novartis, Pfizer; Consultant for: AbbVie, Novartis, Pfizer; Speakers bureau: AbbVie, BMS, MSD, Novartis, Pfizer, UCB, Roche. EP is an employee of Novartis. CK is an employee of ClinProject GmbH, Eurasburg, Germany and consultant for Novartis. AW is an employee of Novartis. FB received grant/research support from AbbVie, Pfizer, Roche, Chugai, Janssen, Novartis and consultancies/speakers fee from AbbVie, Pfizer, Roche, Chugai, UCB, BMS, Celgene, MSD, Novartis, Biotest, Janssen, Sanofi, Genzyme, Lilly, Boehringer, Galapagos.